BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
申请人:Acadia Pharmaceuticals Inc.
公开号:EP1432420B1
公开(公告)日:2011-07-13
US7087593B2
申请人:——
公开号:US7087593B2
公开(公告)日:2006-08-08
US7273857B2
申请人:——
公开号:US7273857B2
公开(公告)日:2007-09-25
[EN] BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS<br/>[FR] DERIVES DE BENZIMIDAZOLIDINONE UTILISES COMME AGENTS MUSCARINIQUES
申请人:ACADIA PHARM INC
公开号:WO2003028650A2
公开(公告)日:2003-04-10
Benzimidazolidinone derivative compounds, which increase acetylcholine signalling or effect in the brain, and highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.